BBOT — BridgeBio Oncology Therapeutics Inc. stock price, charts and financials

QT22BridgeBio Oncology Therapeutics Inc.

BridgeBio Oncology Therapeutics Inc. (NASDAQ: BBOT) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
8.87
+0.62+7.52%
OverviewShort InterestFilings
BBOTQT22BridgeBio Oncology Therapeutics Inc.·NASDAQ
8.87+7.52%
TA
Loading chart...
Short Interest History· Twice monthly
Settlement DateShort InterestAvg Daily VolumeShares FloatShort Float %Short Ratio
Jul-15-265.69M462.81K452.99K7.10%12.29
Jun-30-265.21M456.35K452.99K6.51%11.42
Jun-15-263.94M359.50K452.99K4.92%10.96
May-29-263.87M347.87K452.99K4.83%11.11
May-15-263.28M326.50K452.99K4.09%10.03
Apr-30-263.32M317.51K452.99K4.15%10.46
Apr-15-263.24M261.93K452.99K4.04%12.36
Mar-31-262.39M270.69K452.99K2.99%8.85
Mar-13-262.26M277.68K452.99K2.82%8.13
Feb-27-262.33M280.99K452.99K2.91%8.29
Feb-13-262.34M255.60K452.99K2.92%9.16
Jan-30-262.16M231.24K452.99K2.70%9.34